Status:
COMPLETED
Fluvastatin Versus Hepatitis C Virus
Lead Sponsor:
Bader, Ted, M.D.
Collaborating Sponsors:
US Department of Veterans Affairs
Conditions:
Hepatitis C
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.
Detailed Description
Four different oral doses of fluvastatin will be used for 14 days and the viral load of hepatitis C will be measured weekly. This has been extended to different doses for 9-12 weeks.
Eligibility Criteria
Inclusion
- HCV RNA positive
Exclusion
- Testing positive for alcohol or marijuana
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
End Date :
September 1 2007
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00441493
Start Date
September 1 2006
End Date
September 1 2007
Last Update
July 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Medical Center
Oklahoma City, Oklahoma, United States, 73104